EN DE

Indo Acidatama Tbk (SRSN) Fair Value & Analysis

Basic Materials · ID · Market cap 391B IDR (≈ $39.1M) · ISIN ID1000102601

IA Indo Acidatama Tbk SRSN · JK
Price74.00 IDR
Fair Value123.97 IDR
Upside+67.5%
Quality75/100
Watch Indo Acidatama Tbk for free, get notified when fair value or trend changes. Watch for free

Strengths

Trades 40% below our fair value of 123.97 IDR
Healthy Growth (revenue 5y +7.1 %/yr)
Low debt · generates free cash flow
Ranks above peers (14/15)

Risks

!Thin margins · 8.2% net margin
!Moderate moat 54/100
Healthy Growth (revenue 5y +7.1 %/yr)
Thin margins · 8.2% net margin
Low debt · generates free cash flow
Ranks above peers (14/15)
Moderate moat 54/100
Evidence: High Range 92.98 IDR – 154.97 IDR Share as image

Fair value as of: Aug 21, 2026

From 26 valuation models · updated 8 days ago

Fair value updated Aug 21, 2026, revised from 218.44 IDR to 123.97 IDR (−43.2%) since Aug 13, 2026. Share price +21.3% over the past month.

A strong business, trading 40% below our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Track Indo Acidatama Tbk and get told automatically when its fair value or trend turns, plus fair value for all 35,000+ stocks. 14 days of Pro free, no card. Track it free

What matters now

  • The rarer combination: high quality (75/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case (92.98 IDR). The market is more pessimistic than our downside scenario.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

75.70 IDR 46.28 IDR Fair Value 123.97 IDR Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 21, 2026.

How to read this chart

60‑month range 46.28 IDR – 75.70 IDR · fair‑value band 92.98 IDR – 154.97 IDR · the 74.00 IDR price screens below the 123.97 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 21, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Indo Acidatama Tbk (SRSN) currently trades at 74.00 IDR, while our model-based Fair Value estimate is 123.97 IDR, implying the stock looks roughly 67.5% undervalued today. The Quality Score stands at 75/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Indo Acidatama Tbk generated revenue of 1.2T IDR at a net margin of 8.2%. Revenue declined 23.3% year over year. It earns a return on equity of 12.2%. Net debt stands at 104B IDR. Fundamentals as of Aug 21, 2026

Our scenario range runs from 92.98 IDR (bear case) to 154.97 IDR (bull case); at 74.00 IDR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 9% below its 52-week high and 54% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -48% fair-value upside, at 68%, SRSN screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 469.12 IDR 789.09 IDR 1,336 IDR 80
Residual Income 118.26 IDR 131.68 IDR 230.65 IDR 76
Rev-Margin DCF 266.34 IDR 401.35 IDR 566.20 IDR 74
All 26 models by family
DCF Models
FCF DCF 464.09 IDR 787.39 IDR 1,334 IDR 38
Owner Earnings 131.18 IDR 222.04 IDR 375.53 IDR 31
5Y Revenue Exit 266.34 IDR 398.04 IDR 564.17 IDR 39
5Y EBITDA Exit 254.70 IDR 375.36 IDR 514.61 IDR 41
5Y P/E Exit 251.03 IDR 368.21 IDR 491.63 IDR 38
10Y Revenue Exit 323.38 IDR 465.90 IDR 657.97 IDR 36
10Y EBITDA Exit 321.57 IDR 449.43 IDR 617.76 IDR 37
10Y P/E Exit 319.14 IDR 444.24 IDR 599.11 IDR 35
Earnings-Based
Graham-Dodd 87.37 IDR 326.40 IDR 441.32 IDR 54
Lynch FV 78.61 IDR 112.30 IDR 145.99 IDR 50
PEG = 1.0 78.61 IDR 112.30 IDR 145.99 IDR 46
EPV 156.02 IDR 183.37 IDR 207.68 IDR 59
Dividend Discount
Gordon GGM 9.61 IDR 20.99 IDR 35.32 IDR 70
DDM Multi-Stage 9.61 IDR 17.19 IDR 21.88 IDR 61
Multiples
P/E Multiple 163.83 IDR 218.44 IDR 273.05 IDR 63
P/S Multiple 163.83 IDR 218.44 IDR 273.05 IDR 58
P/B Multiple 163.83 IDR 218.44 IDR 273.05 IDR 55
EV/EBIT 204.40 IDR 272.18 IDR 339.96 IDR 53
EV/EBITDA 170.87 IDR 227.47 IDR 284.08 IDR 54
EV/Revenue 177.28 IDR 252.81 IDR 328.34 IDR 43
Asset-Based
NCAV (Graham) 67.26 IDR 90.13 IDR 134.52 IDR 50
Growth DCF
Growth DCF 469.12 IDR 789.09 IDR 1,336 IDR 80
Rev-Margin DCF 266.34 IDR 401.35 IDR 566.20 IDR 74
Economic Profit
Residual Income 118.26 IDR 131.68 IDR 230.65 IDR 76
ROIC Compounder 164.11 IDR 220.31 IDR 299.46 IDR 72
Growth Earnings
Growth-Adj P/E 128.45 IDR 183.50 IDR 238.56 IDR 68

Widest divergence: Growth DCF (401.35 IDR) versus Dividend Discount (17.19 IDR). Highest evidence: Growth DCF (80).

Notify me when SRSN reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 4.6
P/S ratio 0.28 P/E × margin
EPS (TTM) 16.03 IDR price ÷ EPS = P/E 4.6
Net margin 6.2% FY2025
Return on equity 12.2% TTM
Return on assets (EBIT) 7.6% avg 5y
More key figures
Profitability
Operating margin 15.7% TTM
Growth
Revenue (TTM) 1.2T IDR TTM
Revenue growth (YoY) -23.3% 3y avg +8.7%
EPS growth (YoY) +197%
Balance sheet & cash flow
Free cash flow 221B IDR FY2025
Net debt 104B IDR FY2025 · ≈ 0.5 yrs of FCF

Figures from reported company fundamentals · as of Aug 21, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 75/100

Of which business quality 74 · Market factors (momentum, volatility) 61

Profitability 54
Margins and returns on capital today
Quality Growth 89
Are margins and returns improving?
Cashflow 83
Earnings quality: real cash, not paper profit
Fin. Strength 68
Balance sheet, leverage, solvency risk
Investment 76
Disciplined investing over empire-building
Low Volatility 61
Calm price path (market factor)
Momentum 58
Price trend over the last 3–12 months (market factor)
52W Momentum 64
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

PT Indo Acidatama Tbk operates as an agro-chemical company in Indonesia. The company offers ethanol and acetic acid products; and agro products, such as liquid biofertilizer, organic fertilizer, decomposer, liquid organic fertilizer, liquid organic soil conditioner, and bio-organic fertilizer, as well as farm, fishery, and other products.

Full company description

PT Indo Acidatama Tbk operates as an agro-chemical company in Indonesia. The company offers ethanol and acetic acid products; and agro products, such as liquid biofertilizer, organic fertilizer, decomposer, liquid organic fertilizer, liquid organic soil conditioner, and bio-organic fertilizer, as well as farm, fishery, and other products. It also exports its products. The company was formerly known as PT Sarasa Nugraha Tbk and changed its name to PT Indo Acidatama Tbk in May 2006. PT Indo Acidatama Tbk was founded in 1982 and is headquartered in Jakarta, Indonesia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Indo Acidatama Tbk reported revenue of 1.3T IDR in FY2025 versus 908B IDR in FY2021, a compound +8.5%/yr. Reported net income was 77.4B IDR in FY2025, compounding +30.7%/yr from FY2021.

Growth Quality 79/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
1.3T IDR
Latest YoY
+8.9%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.7%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.1%
Avg. revenue growth/yr (25Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.4%
Value creation/yr (5Y, in IDR) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+12.6% (12.6 + 0.0)
Revenue +8.5%/yr
FY21 908B IDR
FY22 978B IDR
FY23 1.0T IDR
FY24 1.2T IDR
FY25 1.3T IDR
Net income +30.7%/yr
FY21 26.5B IDR
FY22 33.6B IDR
FY23 58.0B IDR
FY24 22.5B IDR
FY25 77.4B IDR
Character of growth · EPS growth decomposed (2014-2025) +16.2 % p.a.
Revenue per share +9.6 pp

of which total revenue +9.6 pp · buybacks/dilution +0.0 pp

EBIT margin +1.6 pp
Tax rate −0.2 pp
Residual (interest, one-offs) +5.1 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch SRSN: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Indo Acidatama Tbk Fair Value". https://www.fairvalue-calculator.com/stock/SRSN

Peer Group

Chemicals · 347 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 75 · Top 25%
Fair Value upside +68% · Top 25%
Return on equity (TTM) 12% · Top 25%
Return on assets 8% · Top 25%
Net margin (TTM) 8% · Above median
Operating margin (TTM) 16% · Top 25%
Revenue growth -23% · Bottom 25%
Dividend yield (TTM) 1.7% · Above median

Valuation Multiples vs Chemicals median · lower = cheaper

P/E (TTM) 4.6× · Cheaper than 75% of peers
P/B 0.48× · Cheaper than 75% of peers
P/S (TTM) 0.33× · Cheaper than 75% of peers
P/FCF 0.0× · Cheaper than 75% of peers
EV/EBITDA 2.5× · Cheaper than 75% of peers
PEG 0.11× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 0
FUTURE0 · sector 20
PAST49 · sector 20
HEALTH100 · sector 94
DIVIDEND34 · sector 31

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 21, 2026).

Stock Price Fair Value vs Fair Value
Saudi Basic Industries Corporation 2010 49.50 SAR 18.13 SAR -63%
A. Schulman, Inc SLMNP $849.00 $203.64 -76%
Ningxia Baofeng Energy Group 600989 ¥23.43 ¥20.17 -14%
Dow Inc DOW $30.33 $21.03 -31%
Zhejiang Juhua Co 600160 ¥41.32 ¥21.62 -48%
Rongsheng Petrochemical Co 002493 ¥13.76 ¥2.39 -83%
Zangge Mining Company 000408 ¥78.04 ¥20.99 -73%
PT Barito Pacific Tbk, BRPT 1,855 IDR 1,584 IDR -15%
Ganfeng Lithium Group 002460 ¥54.13 ¥16.17 -70%
Hengli Petrochemical Co 600346 ¥18.87 ¥17.09 -9%

Compare Indo Acidatama Tbk with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Indo Acidatama Tbk (SRSN) overvalued or undervalued?
As of Aug 21, 2026, our model estimates a fair value of 123.97 IDR versus a price of 74.00 IDR, about +68% (undervalued).
What is the fair value of SRSN?
Our model-based fair value for Indo Acidatama Tbk is 123.97 IDR (as of Aug 21, 2026), built from audited fundamentals. The current price: 74.00 IDR.
What is the quality score of SRSN?
Indo Acidatama Tbk has a Quality Score of 75/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Indo Acidatama Tbk (SRSN)?
Indo Acidatama Tbk reported trailing-twelve-month revenue of about 1.2T IDR (latest available figure, as of Aug 21, 2026).
What is the net profit margin of SRSN?
The net profit margin of Indo Acidatama Tbk is about 8.2%, meaning it keeps roughly 8.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free · no account needed

Watch Indo Acidatama Tbk in the live analysis

One click puts Indo Acidatama Tbk on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.